Complications of Prosthetic Heart Valves

Thromboembolism

• Mechanical valves create abnormal blood flow patterns with stasis zones in sewing rings and recesses, promoting platelet adhesion and fibrin deposition on valve surfaces
• Bioprosthetic valves have inherently lower thrombogenicity but still generate microthrombi at suture lines and along valve commissures
• Tissue factor exposure from endothelial disruption initiates the extrinsic coagulation cascade; deficient anticoagulation allows thrombus propagation
• Left atrial appendage thrombus formation occurs with atrial fibrillation due to blood stasis, compounded by mechanical valve turbulence
• Thrombus can embolize to cerebral, peripheral, coronary, or mesenteric circulation

Structural Valve Deterioration (SVD)

• Bioprosthetic degeneration results from chronic mechanical stress causing collagen fragmentation, elastin disruption, and calcification in valve leaflets
• Calcification proceeds through several stages: initial mineral deposition at leaflet edges → progressive calcification of collagen matrix → leaflet rigidity and immobility
• Pannus formation (fibrous overgrowth) occurs as organizing thrombus on the atrial surface, causing leaflet restriction independent of calcification
• Immunologic factors including xenogeneic rejection and molecular mimicry between porcine antigens and human tissues accelerate deterioration
• Risk factors include younger age at implantation (greater cumulative exposure), hypercalcemia, renal failure, and female gender

Infective Endocarditis

• Bacterial seeding at sewing ring interfaces where endothelialization is incomplete creates a protected nidus for biofilm formation
• Mechanical valves have higher endocarditis rates than bioprosthetic valves due to greater turbulence and suture line exposure
• S. aureus is the most common causative organism, particularly in early prosthetic valve endocarditis (PVE < 12 months post-implant), reflecting skin contamination during surgery
• Streptococci predominate in late PVE (>12 months), often originating from dental procedures or poor oral hygiene
• Vegetation formation leads to perivalvular abscess development, causing paravalvular regurgitation, conduction abnormalities, and hemodynamic collapse

Hemolysis

• Mechanical valve closure creates high shear forces exceeding 4000 dyne/cm² that directly traumatize passing red blood cells
• Paravalvular regurgitation creates an additional jet of high-velocity flow through an abnormal pathway, increasing shear stress
• Red blood cell membrane rupture releases hemoglobin into circulation, causing schistocyte formation; severe cases produce acute intravascular hemolysis
• Haptoglobin is rapidly consumed binding free hemoglobin; excess free hemoglobin undergoes glomerular filtration causing hemoglobinuria and renal dysfunction
• LDH elevation with preserved or only mildly elevated indirect bilirubin is characteristic of chronic hemolysis

Mechanical Dysfunction

• Ball variance (ball escape from cage) occurs with primary ball material degradation or sewing ring fracture in older Starr-Edwards valves
• Strut fracture results from metal fatigue from repetitive mechanical stress at weak points in valve architecture (particularly first-generation models)
• Leaflet escape in bileaflet valves occurs when calcification or thrombus prevents proper coaptation
• Disk jamming in single-disk valves results from thrombus, pannus, or vegetations wedging in the occluder mechanism

Thromboembolism Risk Factors

• Mechanical valve type: Ball-cage > tilting disk > bileaflet > bioprosthetic
• Valve position: Mitral > aortic (higher left atrial pressure favors stasis)
• Suboptimal anticoagulation (INR <2 for most mechanical valves)
• Atrial fibrillation (3-fold increased risk)
• Hypercoagulable states: malignancy, thrombophilia, antiphospholipid syndrome
• Left ventricular dysfunction and reduced cardiac output
• Endocarditis with vegetations

Structural Valve Deterioration

• Younger age at implantation (inverse correlation with durability; <40 years old at 15-year freedom from SVD is only 50% for porcine bioprostheses)
• Female gender (accelerated calcification; gender-age interactions may reflect pregnancy-related hemodynamic changes)
• Renal insufficiency and secondary hyperparathyroidism (hypercalcemia-driven calcification)
• Diabetes mellitus
• Hypertension with inadequate control
• High-flow bioprostheses (stentless valves) show paradoxically earlier structural deterioration

Infective Endocarditis

• Timing of PVE: Early (<2 months post-op) suggests intraoperative seeding with S. aureus, coagulase-negative staphylococci, or gram-negative organisms
• Late PVE (>2 months) typically follows bacteremia from dental procedures, gastrointestinal instrumentation, or intravenous drug use
• S. aureus in IV drug users with prosthetic valves suggests health-care associated infection or line-related bacteremia
• Immunosuppression (post-transplant) increases PVE incidence 6-fold
• Hemodialysis with vascular access infections

Hemolysis

• Paravalvular regurgitation (most common cause, accounts for 90% of clinically significant hemolysis)
• Mechanical valve closure mechanisms (especially ball-cage and tilting-disk designs)
• Increasing age of prosthetic valve with progressive wear
• Anemia predisposing to compensatory high-flow states and increased shear stress

Mechanical Dysfunction

• Valve age and design: Starr-Edwards ball-cage and Bjork-Shiley convex disk valves have highest strut fracture rates (1-3% annually in older versions)
• Manufacturing defects (Bjork-Shiley convex disk 60° model: 0.2% annual strut fracture rate)
• Pannus formation (slow, progressive)
• Thrombosis (acute, often catastrophic)
• Structural calcification in bioprostheses

Thromboembolism

• Acute ischemic stroke with focal neurological deficits (hemiparesis, aphasia, hemianopia)
• Transient ischemic attack with complete symptom resolution
• Peripheral arterial occlusion causing acute limb ischemia with pain, coolness, pallor
• Mesenteric ischemia presenting with acute severe abdominal pain out of proportion to exam findings
• Myocardial infarction if thromboembolism occludes coronary artery
• Asymptomatic thrombus discovered incidentally on echocardiography

Structural Valve Deterioration

• Progressive dyspnea on exertion reflecting increasing valve insufficiency
• Syncope or presyncope from critical stenosis
• New or changing murmur on cardiac auscultation
• Heart failure symptoms: orthopnea, paroxysmal nocturnal dyspnea, peripheral edema
• Insidious symptom onset over months to years

Infective Endocarditis

• Fever (present in 90% of cases, though may be absent in elderly or immunosuppressed)
• New murmur (regurgitation murmur from perivalvular leak or vegetations)
• Septic emboli causing pulmonary infarcts (pleurisy, hemoptysis in right-sided endocarditis)
• Acute decompensated heart failure from large vegetations or aortic root abscess
• Embolic phenomena: splinter hemorrhages (nailbeds), Osler nodes (fingertip pads), Janeway lesions (palms/soles), petechiae
• Acute stroke from septic cerebral embolism
• Splenomegaly from septic emboli and infarction

Hemolysis

• Progressive fatigue and dyspnea from anemia
• Jaundice from elevated indirect hyperbilirubinemia (though often mild with chronic hemolysis)
• Dark urine (hemoglobinuria) or cola-colored urine in acute intravascular hemolysis
• Syncope from severe anemia
• Elevated reticulocyte count (appropriate marrow response) with preserved or high-normal hematocrit suggests chronic compensated hemolysis
• Abdominal pain from renal infarction due to hemoglobin precipitation

Mechanical Dysfunction

• Sudden valve closure (ball variance, strut fracture): acute onset severe dyspnea, pulmonary edema, cardiogenic shock, syncope
• Stuck open valve: acute regurgitation causing pulmonary edema and hemodynamic collapse
• Gradual restriction with progressive dyspnea (pannus, calcification)
• "Hung-up" prosthetic valve with muffled or altered click on auscultation

Hemolysis Associated with Paravalvular Regurgitation

• New holosystolic murmur at the site of the paravalvular leak (often localized rather than diffuse)
• Progressive anemia despite increased reticulocyte response
• Transfusion dependence in severe cases

Transthoracic Echocardiography (TTE)

• Initial imaging modality; limited by acoustic windows, especially in mechanical valves which create acoustic artifacts
• Can assess mechanical valve motion, measuring opening/closing angles and rates
• Doppler assessment reveals increased mean gradients across stenotic valves or regurgitation jets
• Mechanical valve: normal opening velocity 4-5 m/s; delayed opening or closure suggests pannus or thrombus
• Bioprosthetic degeneration: thickening >3 mm, restricted leaflet motion, eccentric jets indicating regurgitation
• Limited ability to visualize perivalvular abscesses due to shadowing from mechanical valve material

Transesophageal Echocardiography (TEE)

• Superior imaging without acoustic interference from mechanical valves
• Gold standard for diagnosis of prosthetic valve endocarditis, visualizing vegetations, perivalvular abscesses, and paravalvular regurgitation
• Vegetations appear as oscillating, echodense masses on valve or adjacent endocardium
• Perivalvular abscess: localized echo-free space with disrupted valve architecture
• Can quantify degree of aortic root involvement and predict need for surgical intervention
• Detects occult thrombi on mechanical valves (appears as layered echodensity on valve surface)
• Sensitivity approaches 90% for endocarditis compared to 50-60% with TTE

Fluoroscopy

• Real-time assessment of mechanical valve motion comparing opening/closing patterns
• Cine-fluoroscopy reveals stuck valves (no motion), delayed closure, or asymmetric leaflet excursion
• Can detect strut fractures as radiolucencies in the valve housing
• Ball variance evident as ball position outside the cage
• Less commonly used given superior imaging with echo but valuable when echocardiographic windows are poor

Blood Cultures

• Multiple sets (3-4) drawn before antibiotic administration essential for accurate organism identification
• Positive cultures in 85-90% of native valve endocarditis, only 60-70% of prosthetic valve endocarditis (especially early PVE)
• HACEK organisms require prolonged incubation (up to 21 days) and often initially missed
• Culture-negative endocarditis suggests fastidious organisms (Coxiella, Brucella, Bartonella) or inadequate culture techniques

Laboratory Studies

• Complete blood count: Anemia with elevated reticulocyte count (>2%) indicates hemolysis; schistocytes on peripheral smear
• Lactate dehydrogenase (LDH): Markedly elevated (often >500 U/L) in intravascular hemolysis; exceeds aspartate aminotransferase
• Haptoglobin: Decreased or undetectable with hemolysis (normal 30-200 mg/dL)
• Indirect bilirubin: Elevated but typically modest (1-3 mg/dL) even with significant hemolysis
• Urinalysis: Hemoglobinuria present in acute intravascular hemolysis (dipstick positive for blood without RBCs on microscopy)
• Creatinine: Elevated if acute renal injury from hemoglobin-induced tubular necrosis
• INR/PT: Assess anticoagulation adequacy in mechanical valve recipients; target INR varies by valve type and position

Inflammatory Markers

• Erythrocyte sedimentation rate (ESR): Elevated, nonspecific
• C-reactive protein (CRP): Elevated but less specific than in native valve endocarditis; may be normal in prosthetic valve endocarditis

Modified Duke Criteria for Prosthetic Valve Endocarditis

• Major criteria:
• Positive blood cultures (organism typical for endocarditis × 2 or persistently positive)
• TEE evidence of vegetations, perivalvular abscess, or new paravalvular regurgitation
• New conduction abnormality (atrioventricular block)
• Minor criteria:
• Fever >38.0°C
• Vascular phenomena (emboli, splinter hemorrhages, mycotic aneurysm)
• Immunological phenomena (rheumatoid factor, circulating immune complexes)
• Modified minor criterion for prosthetic valves: ESR >100 mm/hr or CRP >3.0 mg/dL
• Diagnosis requires: 2 major, 1 major + 3 minor, or 5 minor criteria (modified for prosthetic valves due to lower sensitivity of clinical findings)

Cardiac Computed Tomography (CT)

• Excellent visualization of valve calcification and pannus formation
• Can detect paravalvular abscesses better than echocardiography
• Used when TEE is contraindicated or nondiagnostic
• Limited ability to assess hemodynamics compared to Doppler echocardiography

Cineangiography

• Rarely used except in unique cases where prosthetic valve pathology affects coronary anatomy
• Direct visualization of regurgitation jets and valve morphology

Cardiac Magnetic Resonance (CMR)

• Contraindicated in most mechanical valve recipients due to ferromagnetic properties causing artifact
• Some newer low-ferromagnetic valves (e.g., On-X valve) allow CMR imaging
• Useful for myocardial characterization in embolic events (acute infarction patterns)

Thromboembolism Prevention in Mechanical Valves

• Warfarin (target INR 2.5-3.5 for mitral position; 2.0-3.0 for aortic)
• Mechanism: Vitamin K-dependent factor inhibition (II, VII, IX, X)
• Dosing individualized based on INR monitoring; therapeutic level achieved by day 3-5
• Bridging with unfractionated heparin required if INR subtherapeutic perioperatively
• Aspirin 75-100 mg daily in addition to warfarin reduces thromboembolic events by 30-50% (particularly beneficial in mechanical aortic valves)
• Clopidogrel 75 mg daily added to aspirin/warfarin in high-risk patients (prior thromb

Emergencies — recognize immediately

• Obstructive mechanical valve thrombosis: thrombus wedges the occluder, converting the prosthesis to a fixed stenosis. Signals: acute dyspnea/pulmonary edema or shock, muffled or absent prosthetic click, new/louder gradient on Doppler, restricted leaflet excursion on cine-fluoroscopy. The ACC/AHA valvular heart disease guideline treats obstructive left-sided thrombosis as a surgical emergency, with fibrinolysis as an alternative in patients with small thrombus burden and low functional class or prohibitive surgical risk.
• Acute mechanical failure (strut fracture, leaflet/disc escape, ball variance): abrupt torrential regurgitation with flash pulmonary edema and cardiogenic shock. Requires emergent operation; no medical therapy substitutes.
• Prosthetic valve endocarditis with heart failure, abscess, or new AV block: infection tracks along the sewing ring into the annulus and aortic root, dehiscing the valve (rocking prosthesis) and burrowing toward the conduction system. New conduction delay in aortic PVE is the classic clue to root abscess and, per ACC/AHA and AHA endocarditis guidance, prompts early surgery plus prolonged pathogen-directed therapy.
• Systemic embolism: acute stroke, acute limb ischemia, or mesenteric ischemia with pain out of proportion to exam.

Subacute and chronic complications

• Structural valve deterioration: leaflet calcification and tearing in bioprostheses producing mixed stenosis/regurgitation over years; heralded by rising gradients and a new murmur. Managed by redo surgery or valve-in-valve transcatheter replacement.
• Pannus ingrowth: fibrous tissue restricts the occluder gradually; suggested by high gradients without visible thrombus and no response to anticoagulation — CT and fluoroscopy help distinguish it from thrombus.
• Paravalvular leak with mechanical hemolysis: shear across the eccentric jet produces schistocytes, high LDH, low haptoglobin, negative Coombs test.

Complications of therapy

• Anticoagulant hemorrhage: intracranial and GI bleeding are the dominant iatrogenic risks; heparin bridging adds HIT risk.
• Warfarin embryopathy with first-trimester exposure, a central issue in valve choice for women of childbearing age.
• Reoperation and transcatheter risks: conduction block requiring permanent pacing and coronary obstruction during valve-in-valve procedures.

• Mechanical valve = warfarin, never a DOAC: direct oral anticoagulants are contraindicated with mechanical prostheses; the RE-ALIGN trial of dabigatran was stopped for excess thromboembolism and bleeding. Choosing apixaban for a mechanical mitral valve is the classic wrong answer. Vitamin K antagonism is also the reason warfarin is used despite pregnancy risk.
• Fever in a prosthetic valve patient: draw at least three sets of blood cultures from separate sites before antibiotics, then obtain TEE — a negative TTE never excludes prosthetic valve endocarditis because valve material shadows the annulus.
• Muffled or absent prosthetic click plus acute pulmonary edema is obstructive valve thrombosis. Best next step is urgent imaging (TEE plus cine-fluoroscopy) with immediate surgical consultation; the ACC/AHA guideline favors emergency surgery for left-sided obstructive thrombosis with advanced symptoms.
• New AV block after aortic valve replacement with fever = perivalvular/root abscess. The examiners want surgery, not another antibiotic course.
• Anemia + schistocytes + high LDH + low haptoglobin + negative direct Coombs in a valve patient = mechanical hemolysis from paravalvular regurgitation. Do not diagnose TTP and do not start plasma exchange; get a TEE to find the leak.
• Endocarditis prophylaxis: per the AHA/ACC, any prosthetic valve or prosthetic material used for valve repair warrants amoxicillin 2 g PO (single dose before the procedure) for dental work involving gingival manipulation or oral mucosal perforation. Prophylaxis is not indicated for GI or GU procedures.
• Valve-choice association: bioprostheses spare the patient anticoagulation but deteriorate fastest in young patients and those with chronic kidney disease; mechanical valves last but obligate lifelong warfarin.
• Subtherapeutic INR is the single most common precipitant of both valve thrombosis and embolic stroke — always check the INR in the stem before reaching for an exotic diagnosis.